Newsfeeds Archive - Page 400 of 461

1 minute read

Gilead’s Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme

September 29, 7:10 AM

U.S. District Judge Ann Donnelly has ordered to freeze several assets related to people and entities accused of operating a U.S. supply chain that distributes counterfeit bottles of Gilead Sciences Inc's (NASDAQ: GILD) HIV drugs.

GILD

1 minute read

Amazon Unveils First Of Its Kind Bedside Sleep Tracker: Checkout Features

By Vandana Singh

September 29, 6:57 AM

Amazon.com Inc (NASDAQ:AMZN) announced a contactless gadget that can monitor people’s sleep. The online retailer said its $139.99 sleep gadget, dubbed…

AAPL

1 minute read

Amid Challenging Backdrop, This Analyst Previews Teladoc Health’s Upcoming Q3 Earnings

By Vandana Singh

September 28, 3:20 PM

RBC Capital Markets has cut the price target for Teladoc Health Inc (NYSE:TDOC) from $53 to $35 but reiterates the Outperform rating.…

TDOC

1 minute read

PepGen’s Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta’s Candidate, Says Analyst

By Vandana Singh

September 28, 1:59 PM

PepGen Inc (NASDAQ:PEPG) reported data from PGN-EDO51’s SAD study in adult healthy volunteers that suggest best-in-class exon skipping capabilities. SVB notes…

PEPG

1 minute read

MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders

By Vandana Singh

September 28, 12:39 PM

MaxCyte Inc (NASDAQ: MXCT) has signed a

CRSP

1 minute read

Rallybio’s Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets

By Vandana Singh

September 28, 12:37 PM

Rallybio Corporation (NASDAQ:RLYB) announced preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212 to prevent fetal and neonatal alloimmune…

RLYB

1 minute read

KemPharm’s Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder

By Vandana Singh

September 28, 12:07 PM

KemPharm Inc (NASDAQ:KMPH) announced topline data from its exploratory Phase 1 trial confirming the relative cardiovascular effects and pharmacokinetics of serdexmethylphenidate…

KMPH

1 minute read

OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test

By Vandana Singh

September 28, 10:28 AM

The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ:OSUR) for developing a…

OSUR

1 minute read

ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate

By Vandana Singh

September 28, 10:24 AM

ASLAN Pharmaceuticals (NASDAQ:ASLN) announced the presentation of new translational eblasakimab data at the Annual European Society for Dermatological Research (ESDR) Meeting. …

ASLN

1 minute read

Europe’s Health Agency Accepts Moderna’s Filing For Its Updated Omicron-Targeted COVID-19 Vaccine

By Vandana Singh

September 28, 10:16 AM

The European Medicines Agency (EMA) has accepted a variation for evaluating Moderna Inc’s (NASDAQ:MRNA) 50 µg booster dose of the Omicron-containing…

MRNA